CONTEXT: Hyperoside (Hyp), one of the active flavones from Rhododendron (Ericaceae), has beneficial effects against cerebrovascular disease. However, the effect of Hyp on vasodilatation has not been elucidated. OBJECTIVE: To explore the effect of Hyp on vasodilatation in the cerebral basilar artery (CBA) of Sprague-Dawley (SD) rats suffering with ischaemic-reperfusion (IR) injury. MATERIALS AND METHODS: Sprague-Dawley rats were randomly divided into sham, model, Hyp, Hypâ+âchannel blocker and channel blocker groups. Hyp (50âmg/kg, IC(50)â=â18.3âμg/mL) and channel blocker were administered via tail vein injection 30âmin before ischaemic, followed by 20âmin of ischaemic and 2âh of reperfusion. The vasodilation, hyperpolarization, ELISA assay, haematoxylin-eosin (HE), Nissl staining and channel-associated proteins and qPCR were analysed. Rat CBA smooth muscle cells were isolated to detect the Ca(2+) concentration and endothelial cells were isolated to detect apoptosis rate. RESULTS: Hyp treatment significantly ameliorated the brain damage induced by IR and evoked endothelium-dependent vasodilation rate (47.93â±â3.09% vs. 2.99â±â1.53%) and hyperpolarization (-8.15â±â1.87âmV vs. -0.55â±â0.42âmV) by increasing the expression of IP3R, PKC, transient receptor potential vanilloid channel 4 (TRPV4), IK(Ca) and SK(Ca) in the CBA. Moreover, Hyp administration significantly reduced the concentration of Ca(2+) (49.08â±â7.74% vs. 83.52â±â6.93%) and apoptosis rate (11.27â±â1.89% vs. 23.44â±â2.19%) in CBA. Furthermore, these beneficial effects of Hyp were blocked by channel blocker. DISCUSSION AND CONCLUSIONS: Although Hyp showed protective effect in ischaemic stroke, more clinical trial certification is needed due to the difference between animals and humans.
Hyperoside ameliorates cerebral ischaemic-reperfusion injury by opening the TRPV4 channel in vivo through the IP(3)-PKC signalling pathway.
阅读:5
作者:Shi Lei, Jiang Chenchen, Xu Hanghang, Wu Jiangping, Lu Jiajun, He Yuxiang, Yin Xiuyun, Chen Zhuo, Cao Di, Shen Xuebin, Hou Xuefeng, Han Jun
| 期刊: | Pharmaceutical Biology | 影响因子: | 4.800 |
| 时间: | 2023 | 起止号: | 2023 Dec;61(1):1000-1012 |
| doi: | 10.1080/13880209.2023.2228379 | ||
特别声明
1、本文转载旨在传播信息,不代表本网站观点,亦不对其内容的真实性承担责任。
2、其他媒体、网站或个人若从本网站转载使用,必须保留本网站注明的“来源”,并自行承担包括版权在内的相关法律责任。
3、如作者不希望本文被转载,或需洽谈转载稿费等事宜,请及时与本网站联系。
4、此外,如需投稿,也可通过邮箱info@biocloudy.com与我们取得联系。
